Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Browse our collection of transfection protocols organized by cell type and optimized for payload/application. If you do not find one that works for your specific experiment, use the TransfectionSelect tool to hone in on your optimal transfection conditions.
Find products, citations, and protocols optimized for your transfection experiments. Input information on your experiment type, cell line, and payload to unlock solutions.
Cell Type | Source | Application | Recommended Transfection Reagent | Recommended Transfection SKU | Protocol/ Citation | |
---|---|---|---|---|---|---|
0–9 | ||||||
10T1/2 | Mouse embryonic fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
293-F | Human kidney | Protein Production | 293fectin | 12347-019 | Protocol | |
293T | Human embryonic kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
3T3L1 | Mouse fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
3T3L1 | Mouse fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
786-O | Human renal cell adenocarcinoma cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
A–F | ||||||
A549 | Human lung carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
A549 | Human lung carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
ACHN | Human renal cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
ARPE-19 | Human retina | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
B16-F10 | Mouse melanoma | Plasmid DNA | Lipofectamine | 18324-012 | 18324-020 | Citation |
BAEC | Bovine aortic endothelial cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
BGOV-1 | Human embryonic stem cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
BHK-21 | Hamster kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Breast Adipose Fibroblasts | Human breast adipose | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
C2C12 | Mouse muscle myoblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
C3A | Human hepatocellular Carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
C6 | Rat glioma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Caco-2 | Human colorectal adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Cardiac Fibroblasts | Adult rat heart | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
CaSki | Human cervical carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
CHO K1 | Hamster ovary | Plasmid DNA | Lipofectamine LTX | 15338-100 | 15338-500 | Protocol |
CHO-S | Hamster ovary | Protein Production | FreeStyle MAX Reagent | 16447-100 | 16447-500 | Protocol |
CMMT | Rhesus monkey mammary. tumor | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Cortical Neurons, E18 | Rat brain | Plasmid DNA | Lipofectamine LTX | 15338-100 | 15338-500 | Protocol |
COS 7L | Monkey kidney fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
COS 7L | Monkey kidney fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
CV-1 | Primate kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
CV-1 | Primate kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
D3 | Mouse embryonic stem cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
D3 | Mouse embryonic stem cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Daoy | Human medulloblastoma cell line | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
DL-3 | Mouse T lymphoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
DLD-1 | Human colon adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
DT40 | Chicken Bursa | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Embryonic stem cells in Essential 8 medium | Human embryonic cell | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
Embryonic stem cells in mTeSR1 | Human embryonic cell | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
Embryonic stem cells in StemFlex medium | Human embryonic cell | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
EOC | Human epithelial ovarian cancer | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Foreskin Fibroblast, Primary | Human foreskin | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
G–H | ||||||
Glial Cell | Mouse brain | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
GripTite 293 MSR | Human kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HaCaT | Human immortalized keratinocytes | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HASMC | Human aortic smooth muscle cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HCT116 | Human colon carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HCT116 | Human colon carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
HEK293 | Human embryonic kidney | Co-transfect Plasmid DNA and siRNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HEK293 | Human embryonic kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HEK293 | Human embryonic kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
HeLa S3 | Human cervical carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HeLa S3 | Human cervical carcinoma | Co-transfect Plasmid DNA and siRNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HeLa S3 | Human cervical carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
Hepatocytes, Primary | Mouse liver | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
HepG2 | Human liver carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
HepG2 | Human liver carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Hippocampal Neurons | Rat brain | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Hippocampal Neurons | Rat brain | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HL60 | Human lymphoblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HMEC-1 | Human dermal microvascular endothelial cells | Plasmid DNA | Lipofectamine LTX | 15338-100 | 15338-500 | Protocols |
HMVEC-L | Human lung microvascular endothelial cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
HNSCC | Human head and neck squamous cell carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
HT 29 | Human colon adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HT1080 | Human fibrosarcoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
HT1080 | Human fibrosarcoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HT1376 | Human grade III transitional bladder cell carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Huh-7 | Human hepatocellular carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Huh-7 | Human hepatocellular carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Human Mesenchymal Stem Cells | Human bone marrow | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
Human Mesenchymal Stem Cells | Human bone marrow | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
HUVEC | Human umbilical vein cord | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
HUVEC | Human umbilical vein cord | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
I–M | ||||||
IMR-90 | Human embryonic lung | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
IMR-90 | Human embryonic lung | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Induced pluripotent stem cells in Essential 8 medium | Human somatic cells | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
Induced pluripotent stem cells in mTeSR1 | Human somatic cells | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
Induced pluripotent stem cells in StemFlex medium | Human somatic cells | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
INS-1 | Rat pancreatic {beta}-cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
JEG-3 | Human choriocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Jurkat | Human T-cell leukemia | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
JygMC(A) | Mouse mammary carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
K562 | Human myelogenous leukemia | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
K562 | Human myelogenous leukemia | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
L929 | Mouse fibroblast cell line | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
LC-NCI-H23 | Non-small cell, epid. | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
LNCap | Human prostate cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
LS180 | Human colon carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
LSMC | Human leiomyoma smooth muscle cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
M21 | Human melanoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
McA-RH7777 | Rat hepatoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
MCF 7 | Human breast cancer | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
MCF 7 | Human breast cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
MCF 7 | Human breast cancer | Co-transfect Plasmid DNA and siRNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
MDA-MB-231 | Human breast adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
MDA-MB-435 | Human breast adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
MDA-MB-435 | Human breast adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
MDCK | Madin-Darby canine kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
MDCK | Madin-Darby canine kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
MDM | Human monocyte-derived macrophages | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
ME-180 | Human cervical carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
MEF | Mouse embryonal fibroblast cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Mesangial Cells, Primary | Rat kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | |
mIMCD3 | Murine inner medullary collecting duct | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
MIN6 | Mouse pancreatic {beta}-cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
MLT | Mouse Leydig tumor | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Molt-4 | Human T lymphoblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
MRC-5 | Human lung | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
N–R | ||||||
N2a-APP | Mouse neuroblastoma N2a cells stably expressing human APP695 | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
N-38 | Mouse hypothalamic cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
NB | Human neuroblastoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
NBS | Human Nijmegen breakage syndrome cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
NCI-p60 | Human large cell lung cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
NDHF | Neonatal dermal fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Neonatal Rat Ventricular Cardiomyocyte | Rat heart muscle | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | |
Neural progenitor cells, Primary | Embryonic mouse brain | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Neural stem cell | Human brain cells | Plasmid DNA, mRNA, Cas9 RNP | Lipofectamine Stem | L3000008 | Citation | |
Neuro2A | Mouse brain neuroblastoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Neuro2A | Mouse brain neuroblastoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
NG108-15 | Hybrid of mouse neuroblastoma N18TG2 and rat glioma C6-BU-1 cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
NHFF | Human diploid somatic fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
NIH 3T3 | Mouse embryonic fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
NIH 3T3 | Mouse embryonic fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
NOR-10 (H-2b) | Mouse skeletal muscle cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
NRK | Rat normal kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
NT2 | Human teratocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
NTera2 | Human embryonic carcinoma stem cell | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
OLN-93, Primary | Rat brain glial cultures | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
OLP, Primary | Rat cerebra | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
P19 | Mouse embryonal carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
P19 | Mouse embryonal carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
PC12 | Rat neuronal | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
PC3 | Human prostate adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Rat1 | Rat fibroblast cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
RAW264.7 | Mouse macrophage cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
RPC-C2A | Rat dental pulp cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
S–W | ||||||
S2-013 | Human pancreas | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Saos-2 | Human osteosarcoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
SK-BR3 | Human breast carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
SK-MEL-28 | Human malignant melanoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
SK-N-SH | Human neuroblastoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
SK-N-SH | Human neuroblastoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Protocol |
SK-OV-3 | Human ovarian adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
SNB19 | Human glioblastoma cell line | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
SW1417 | Human colon adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
SW480 | Human colon adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
T47D | Human mammary adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
T98G | Human brain | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
THP-1 | Human monocytic leukemia | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
THP-1 | Human monocytic leukemia | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
U251 | Human glial | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
U2OS | Human osteosarcoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
U87 | Human astrocyte | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
Vero | African green monkey kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | Protocol |
WI-38(VA13) | Normal human fetal lung fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | Citation |
Lipofectamine reagent-specific protocols have been optimized for efficiency, viability, and reproducibility across a broad range of cell types. Search our library to find protocols and citations curated to fit your experimental needs.
Search our extensive collection of FAQs to find the transfection answers you need. Input key terms to discover a collection of carefully curated and regularly updated answers.
For Research Use Only. Not for use in diagnostic procedures.